Global Point of Care Testing Market Analysis Report 2023: Market to Surpass $75 Billion by 2030 - Technological Advancement in POCT to Spur Market Demand
January 19, 2024 04:13 ET
|
Research and Markets
Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles" report has been added to ...
BioLife Sciences (OTCPK: BLFE) Announces Immediate Commercial Availability of a 10-Minute, Ultra-Rapid, Health Canada Approved, COVID-19 Point of Care Test
October 26, 2020 08:00 ET
|
BioLife Sciences Inc.
TORONTO, ONTARIO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – With the high demand for Covid-19 testing, BioLife Sciences (OTCPK: BLFE) is pleased to announce the availability of the...
PositiveID Corporation to Present at the LD MICRO “Main Event” Investor Conference on December 6th
November 27, 2017 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 27, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year
November 14, 2017 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today its financial results for the...
PositiveID’s ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
August 30, 2017 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 30, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation’s (OTCQB:PSID) ExcitePCR subsidiary today announced the FireflyDX-Portable™, a rechargeable, bookbag-sized, realtime...
PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics Market
May 25, 2017 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., May 25, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID”) (OTC:PSIDD), a Life Sciences company focused on detection and diagnostics, announced today it has formed a...
PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market
May 24, 2017 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., May 24, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID”) (OTC:PSIDD), a Life Sciences company focused on detection and diagnostics, announced today it has formed a...
PositiveID Reports First Quarter 2017 Results
May 16, 2017 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., May 16, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a Life Sciences company focused on detection and diagnostics, announced today its...
PositiveID Announces Highlights for First Quarter 2017
May 01, 2017 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., May 01, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today a...
PositiveID Corporation Develops New Firefly Dx Prototype System With Sample Preparation Added to PCR Capabilities
November 10, 2015 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 10, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company with an extensive patent portfolio, announced today...